Deletion of the cytoplasmic domain increases basal shedding of angiotensin-converting enzyme

Biochemical and Biophysical Research Communications

Volumn 314, Issue 4, 2004, Pages 971-975

  Chubb, Anthony J ^a,c   Schwager, Sylva L U ^a   Van Der Merwe, Elizabeth ^a   Ehlers, Mario R W ^b   Sturrock, Edward D ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Pacific Biometrics Inc   (United States)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

ACE; Actin cytoskeleton; CHO; Cytochalasin D; Cytoplasmic domain; Ectodomain shedding

Indexed keywords

CYTOCHALASIN D; DIPEPTIDYL CARBOXYPEPTIDASE; MEMBRANE PROTEIN; MUTANT PROTEIN; PHORBOL ESTER; PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA PROTEASE INHIBITOR; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOSKELETON; DELETION MUTANT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; TESTIS; TISSUE DISTRIBUTION; WILD TYPE;

EID: 0942278964     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.12.198     Document Type: Article

References (15)

1. Urena J.M., Merlos-Suarez A., Baselga J., Arribas J. The cytoplasmic carboxy-terminal amino acid determines the subcellular localization of proTGF-(alpha) and membrane type matrix metalloprotease (MT1-MMP). J. Cell Sci. 112:1999;773-784.
2. Vinogradova O., Velyvis A., Velyviene A., Hu B., Haas T., Plow E., Qin J. A structural mechanism of integrin alpha(IIb)beta(3) "inside-out" activation as regulated by its cytoplasmic face. Cell. 110:2002;587-597.
3. Tomita S., Kirino Y., Suzuki T. A basic amino acid in the cytoplasmic domain of Alzheimer's beta-amyloid precursor protein (APP) is essential for cleavage of APP at the alpha-site. J. Biol. Chem. 273:1998;19304-19310.
4. Amit, T., Amit, T., Hochberg Z., Yogev-Falach M., Youdim M.B., Youdim M.B., Barkey R.J. Shedding of growth hormone-binding protein is inhibited by hydroxamic acid-based protease inhibitors: proposed mechanism of activation of growth hormone-binding protein secretase. J. Endocrinol. 169:2001;397-407.
5. Gutwein P., Oleszewski M., Mechtersheimer S., Agmon-Levin N., Krauss K., Altevogt P. Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells. J. Biol. Chem. 275:2000;15490-15497.
6. Brakebusch C., Varfolomeev E.E., Batkin M., Wallach D. Structural requirements for inducible shedding of the p55 tumor necrosis factor receptor. J. Biol. Chem. 269:1994;32488-32496.
7. Cheng H.J., Flanagan J.G. Transmembrane kit ligand cleavage does not require a signal in the cytoplasmic domain and occurs at a site dependent on spacing from the membrane. Mol. Biol. Cell. 5:1994;943-953.
8. Woodman Z.L., Oppong S.Y., Cook S., Hooper N.M., Schwager S.L., Brandt W.F., Ehlers M.R., Sturrock E.D. Shedding of somatic angiotensin-converting enzyme (ACE) is inefficient compared with testis ACE despite cleavage at identical stalk sites. Biochem. J. 347:2000;711-718.
9. Sadhukhan R., Sen G.C., Ramchandran R., Sen I. The distal ectodomain of angiotensin-converting enzyme regulates its cleavage-secretion from the cell surface. Proc. Natl. Acad. Sci. USA. 95:1998;138-143.
10. Ehlers M.R., Schwager S.L., Scholle R.R., Manji G.A., Brandt W.F., Riordan J.F. Proteolytic release of membrane-bound angiotensin-converting enzyme: role of the juxtamembrane stalk sequence. Biochemistry. 35:1996;9549-9559.
11. Ehlers M.R., Chen Y.N., Riordan J.F. Spontaneous solubilization of membrane-bound human testis angiotensin-converting enzyme expressed in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA. 88:1991;1009-1013.
12. Schwager S.L., Chubb A.J., Scholle R.R., Brandt W.F., Mentele R., Riordan J.F., Sturrock E.D., Ehlers M.R. Modulation of juxtamembrane cleavage (shedding) of angiotensin-converting enzyme by stalk glycosylation: evidence for an alternative shedding protease. Biochemistry. 38:1999;10388-10397.
13. Mohler K.M., Sleath P.R., Fitzner J.N., Cerretti D.P., Alderson M., Kerwar S.S., Torrance D.S., Otten-Evans C., Greenstreet T., Weerawarna K.et al. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature. 370:1994;218-220.
14. Chubb A.J., Schwager S.L., Woodman Z.L., Ehlers M.R., Sturrock E.D. Defining the boundaries of the testis angiotensin I-converting enzyme ectodomain. Biochem. Biophys. Res. Commun. 297:2002;1225-1230.
15. Santhamma K.R., Sen I. Specific cellular proteins associate with angiotensin-converting enzyme and regulate its intracellular transport and cleavage-secretion. J. Biol. Chem. 275:2000;23253-23258.